The new international recognition framework to be put in place next year by the UK Medicines and Healthcare products Regulatory Agency will involve seven partners, including countries that are part of the existing international Access Consortium and Project Orbis initiatives, the MHRA has announced.
The partners whose new drug approvals will be recognized by the UK are Australia, Canada, the EU, Japan, Switzerland,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?